|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
|
|
|
|
|
|
|
|
|
000-52309
|
|
SEC
FILE NUMBER
|
|
|
|
|
|
|
|
|
|
(Check one):
|
|
o
Form 10-K
o
Form 20-F
o
Form 11-K
ý
Form 10-Q
o
Form 10-D
o
Form N-SAR
o
Form N-CSR
|
|
|
|
|
|
|
|
For Period Ended:
|
May 31, 2017
|
|
|
|
|
|
|
|
o
Transition Report on Form 10-K
|
|
|
|
|
|
|
|
o
Transition Report on Form 20-F
|
|
|
|
|
|
|
|
o
Transition Report on Form 11-K
|
|
|
|
|
|
|
|
o
Transition Report on Form 10-Q
|
|
|
|
|
|
|
|
o
Transition Report on Form N-SAR
|
|
|
|
|
|
|
|
For the Transition Period Ended:
|
|
|
|
Read Instruction (on back page) Before Preparing Form.
Please Print or Type.
Nothing in this form shall be construed to imply that
the Commission has verified any information contained herein.
|
|
|
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION
WHOLEHEALTH PRODUCTS, INC.
______________________________________________________________________________________________
Full Name of Registrant
_____________________________________________________________________________________________
Former Name if Applicable
3800 HOWARD HUGHES PKWY.
_______________________________________________________________________________________________
Address of Principal Executive Office
(Street and Number)
LAS VEGAS, NEVADA 89169
_______________________________________________________________________________________________
City, State and Zip Code
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed
without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
|
ý
|
(a)
|
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
|
ý
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
o
|
(c)
|
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III — NARRATIVE
State below in reasonable detail the
reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
The Registrant could not complete the filing of its Quarterly Report on Form 10-Q for the quarter ended May 31, 2017 due
to a delay in obtaining and compiling information required to be included in its Form 10-Q, which delay could not be eliminated
by the Registrant without unreasonable effort and expense.
PART IV — OTHER INFORMATION
|
(1)
|
|
Name and telephone number of person to contact in regard to this notification
|
|
|
|
|
|
|
|
CHARLES STRONGO
|
|
702
|
|
262-6899
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
|
|
|
|
|
|
|
|
|
(2)
|
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
|
|
|
|
Yes
o
No
ý
|
|
|
|
|
|
(3)
|
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
|
|
|
Yes
o
No
ý
|
|
|
|
|
|
|
|
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
|
|
|
|
|
|
|
|
|
WHOLEHEALTH PRODUCTS, INC.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Date:
|
July
18, 2017
|
By:
|
/s/
Charles Strongo
|
|
|
|
|
Name:
Charles Strongo
|
|
|
|
|
Title:
Principal Executive Officer
|
Wholehealth Products (CE) (USOTC:GWPC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Wholehealth Products (CE) (USOTC:GWPC)
Historical Stock Chart
From Nov 2023 to Nov 2024
